ABBV vs LLY
AbbVie Inc · Eli Lilly and Company
Relative return (rebased to 100)
Key stats
| Metric | ABBV | LLY |
|---|---|---|
| Price | $286.74 | $1,279.14 |
| Market Cap | $506.70B | $1.20T |
| P/E | 119.90 | 58.34 |
| P/B | — | 35.54 |
| P/S | 8.28 | 18.47 |
| ROE | — | 60.9% |
| Net Margin | 6.9% | 31.7% |
| Gross Margin | — | — |
| Revenue Growth | 8.6% | 44.7% |
| Dividend Yield | 2.32% | 0.49% |
| EPS | $2.39 | $21.93 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.